Auxly Cannabis Group (XLY) Investor presentation summary

Strategic positioning and market overview

• Mission focuses on enhancing lives with trusted, quality cannabis products and aims for global leadership in the sector.

• Operates as the #3 largest licensed producer in Canada, with coast-to-coast reach and presence in 10 provinces and 2 territories.

• Canadian recreational cannabis market projected to reach CAD $7.4B by 2030, with increasing social acceptance and legal market penetration.

• Canada serves as a global launchpad, leveraging regulatory leadership and export capabilities to access a US $102B global market by 2030.

• Strategic partnership with Imperial Brands supports international expansion and infrastructure.

Brand leadership and operational excellence

• Holds #1 positions in non-infused pre-rolls, all-in-one vapes, and flower categories nationally.

• Eleven consecutive quarters of positive Adjusted EBITDA, reflecting operational efficiency and profitability.

• State-of-the-art cultivation facility in Leamington, Ontario, produces over 100,000 kgs annually and is certified for export.

• Advanced pre-roll automation and R&D partnerships ensure consistent, high-quality products at scale.

• Charlottetown facility leads in vape innovation, with industry-low failure rates and robust product development.

Financial performance and sustainability

• Q1 2026 net revenue reached $39.8M, with a 31% Adjusted EBITDA margin and $12.3M Adjusted EBITDA.

• Trailing twelve months (TTM) net revenue at $159M, Adjusted EBITDA at $49M, and $44M cash flow from operations before working capital.

• Year-over-year improvements in net revenue, gross margin, and Adjusted EBITDA, with sustainable cash flow generation.

• Strong balance sheet with $42.7M net working capital and total debt at 0.9x TTM Adjusted EBITDA.

• Fully diluted share count stands at 1.7B as of March 31, 2026.